<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">
</head>

<body>

<h2>Figure 1. Factors to be considered in deciding to initiate treatment empirically for active tuberculosis (TB) (prior
    to microbiologic confirmation)</h2>

<img alt="Figure 1" src="figure1.png">

<p>Abbreviations: AFB, acid-fast bacilli; HIV, human immunodeficiency virus; IGRA, interferon-γ release assay; Mtb,
    Mycobacterium tuberculosis; TNF, tumor necrosis factor; TST, tuberculin skin test.</p>
<p>Clin Infect Dis, Volume 63, Issue 7, 1 October 2016, Pages 853–867, <a href=https://doi.org/10.1093/cid/ciw566>https://doi.org/10.1093/cid/ciw566</a>
</p>

<p>Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author
    2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For
    permissions, email journals.permissions@oup.com.</p>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
